$35.26 0.00 (0.00%) Novo Nordisk Shs Sponsored American DepositReceipt Repr 1 Sh -B- - New York Stock Exchange, Inc.

Dec. 6, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 35.26
Trade Time: Dec 06 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 35.26
Open: 34.82
Bid: 35.21
Ask: 35.30
  1. 5 Pharma Stocks In Focus On World Diabetes Day

    TalkMarkets | Nov. 14, 2016 | 13:21PM EST
  2. Trump Triumphs

    TalkMarkets | Nov. 9, 2016 | 21:28PM EST
  3. Buy Health Care Now? It All Depends On The Election

    TalkMarkets | Nov. 7, 2016 | 01:10AM EST
  4. Pricing Issues Continue To Weigh On The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 20:01PM EST
  5. Drugs, Finance, Cars, And Fuel

    TalkMarkets | Nov. 1, 2016 | 11:57AM EST
  6. The Daily Shot And Data - October 31, 2016

    TalkMarkets | Oct. 31, 2016 | 10:07AM EST
  7. Global Roundup: Roche, Vale, Novo Nordisk, Teva, Benitec Et Al

    TalkMarkets | Oct. 21, 2016 | 19:05PM EST
  8. Stocks Up After 1st Presidential Debate; Why Tesla Looks Healthiest In Weeks

    IBD | Sep. 27, 2016 | 10:38AM EST
  9. Novo Nordisk, Weyerhaeuser Earnings, Jobs Report On Tap Friday

    Investors Business Daily | Aug. 4, 2016 | 11:26AM EST
  10. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 09:44AM EST
  11. My Favorite Health Care Stocks

    GuruFocus | Jul. 12, 2016 | 14:26PM EST
  12. Benzinga's Top Downgrades

    Benzinga | Feb. 8, 2016 | 09:38AM EST
  13. Worst Performing Industries For February 4, 2016

    Benzinga | Feb. 4, 2016 | 11:37AM EST
  14. The 2016 Nintai Charitable Trust Portfolio: Annual Review

    GuruFocus | Jan. 18, 2016 | 15:36PM EST
  15. Novo Nordisk Files for Regulatory Approval Of Long-Acting Factor IX in EU for Treatment of Haemophilia B

    Benzinga | Jan. 7, 2016 | 05:58AM EST
Trading Center